http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_910c6a1bd10df03ee920029b181e9c64
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Bertagnolli |
| name | Monica M. Bertagnolli Monica M.. Bertagnolli Monica M Bertagnolli |
| given-name | Monica M. Monica M Monica M.. |
| organization-name | Brigham and Women's Hospital, Boston, Massachusetts Division of Surgical Oncology,Brigham and Women's Hospital,Harvard Medical School,Boston,MA Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA 1Surgery and Departments of From the Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA 2Strang Cancer Prevention Center, New York, New York and Departments of; 3Surgery and Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts. Authors' Affiliations: Departments of 1Adult Oncology and 2Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School; Departments of 3Pathology and 4Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts Authors' Affiliations: 1Brigham and Women's Hospital, and 2Massachusetts General Hospital, Boston, Massachusetts, 3Pfizer, Inc., 4Memorial Sloan-Kettering Cancer Center, New York, New York; 5University of Wisconsin, Madison, Wisconsin; 6CCS Associates, Inc., Mountain View, California; 7University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom; 8Harris Methodist Hospital, Ft. Worth, Fort Worth, Texas; 9Regional Gastroenterology Associates of Lancaster, Lancaster, Pennsylvania; 10Sir Charles Gairdner Hospital, Perth, Western Australia, Australia; 11The Royal Melbourne Hospital, Melbourne, Victoria, Australia; 12Nashville Medical Research Institute, Nashville, Tennessee; 13Atlanta Gastroenterology Associates, Atlanta, Georgia; 14St. Paul's Hospital, University of Saskatchewon, Saskatoon, Saskatchewon; Canada, 15National Cancer Institute, Bethesda, Maryland; and 16M. D. Anderson Cancer Center, Houston, Texas Authors' Affiliation: Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts Authors' Affiliations: 1Dana-Farber/Brigham and Women's Cancer Center; 2Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts; and 3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York Brigham and Women’s Hospital, and the Alliance for Clinical Trials in Oncology, Boston, MA 1Department of Surgery, Division of Surgical Oncology, Brigham and Women's Hospital, Boston, Massachusetts. Cancer and Leukemia Group B Statistical Center; Duke University Medical Center, Durham; Southeast Cancer Control Consortium, Goldsboro; University of North Carolina, Chapel Hill, NC; Brigham and Women's Hospital; Eastern Cooperative Oncology Group; Dana-Farber Cancer Institute, Boston; Massachusetts General, North Shore Cancer Center, Danvers, MA; University of California, San Francisco, San Francisco, CA; National Cancer Institute, Bethesda; National Cancer Institute Expanded Participation Project,... Brigham and Women's Hospital, Boston, MA 02115, USA. mbertagnolli@partners.org Brigham and Women's Hospital, Boston, USA. mbertagnolli@partners.org From the Duke Comprehensive Cancer Center, Durham, NC; North Shore University Hospital, Manhasset; Mount Sinai at Queens Hospital Center, Jamaica, NY; Patient Advocates in Research, Danville, CA; Washington University School of Medicine, St Louis, MO; Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA; and Cancer and Leukemia Group B Central Office and University of Chicago Medical Center, Chicago, IL. Division of Surgical Oncology Department of Surgery Brigham and Womens Hospital Boston MA USA Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA; Alan P. Venook and Robert S. Warren, University of California at San Francisco, San Francisco; Margarita Lopatin, Mark Lee, Kim Clark-Langone, Carl Millward, and Steven Shak, Genomic Health, Redwood City, CA; Donna Niedzwiecki and Xing Ye, Alliance Statistics and Data Center, Duke University, Durham, NC; Paula N. Friedman and Richard L. Schilsky, The University of Chicago, Chicago, IL; Wendy Frankel and Richard M. Goldberg, The Ohio State University, Columbus, OH; Najjia N. Mahmoud, University of... Frank A. Sinicrope, Michelle R. Mahoney, Thomas C. Smyrk, Stephen N. Thibodeau, Garth D. Nelson, Daniel J. Sargent, and Steven R. Alberts, Mayo Clinic, Mayo Cancer Center and the North Central Cancer Treatment Group, Rochester, MN; Robert S. Warren, University of California San Francisco, San Francisco, CA; Monica M. Bertagnolli, Brigham and Women's Hospital, Boston, MA; and Richard M. Goldberg, The Ohio State University Comprehensive Cancer Center, Columbus, OH. Brigham and Women's Hospital, Dana Farber Cancer Institute, Boston, MA 02115, USA. Division of Surgical Oncology, Brigham and Women's Hospital, Boston, MA 02115 Department of Surgery, Division of Surgical Oncology, Brigham and Women’s Hospital, Boston, MA Authors' Affiliations: 1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Departments of 2Pathology, 3Medicine, and 4Surgery, Brigham and Women's Hospital and Harvard Medical School; 5Departments of Biostatistics and Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 6CALGB Statistical Center, Duke University Medical Center, Durham, North Carolina; 7Memorial Sloan-Kettering Cancer Center, New York, New York; 8Toledo Community Hospital Oncology Program, NCCTG, Toledo, Ohio; 9Hôpital du Sacré-Coeur de Montréal, NCIC, Montreal, Quebec, Canada; 10Loyola University Stritch School of Medicine, SWOG, Maywood, Illinois; 11Northwestern University, Chicago, Illinois; and 12University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Monica M. Bertagnolli and Mark Redston, Brigham and Women's Hospital; Monica M. Bertagnolli and Robert J. Mayer, Dana-Farber Cancer Institute, Boston, MA; Donna Niedzwiecki, Cancer and Leukemia Group B Statistical Center, Duke University Medical Center, Durham; Richard M. Goldberg, University of North Carolina at Chapel Hill, Chapel Hill, NC; Carolyn C. Compton, National Cancer Institute, Bethesda, MD; Thomas A. Colacchio, Dartmouth Hitchcock Medical Center, Hanover, NH; Leonard B. Saltz, Memorial Sloan... From the Departments of Surgery, Anesthesia, Medical Oncology, Biostatistics and Computational Biology, and Pathology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA Dana-Farber/Brigham and Women’s Cancer Center, Boston, MA Brigham & Women’s Hospital and Dana-Farber Cancer Institute, Boston, MA Authors' Affiliations: 1Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; 2Department of Biostatistics and Bioinformatics, Alliance Statistics and Data Center, Duke University Medical Center, Durham, North Carolina; 3Dana-Farber Cancer Institute; 4Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts; 5The Ohio State University, Columbus, Ohio; 6National Cancer Institute, Bethesda, Maryland; and 7Memorial Sloan-Kettering Cancer Center, New York, New York Department of Surgery, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA; Center for Sarcoma and Bone Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA Authors' Affiliations: 1Division of Medical Oncology; 2Alliance Statistics and Data Center, Duke University Medical Center; Durham, North Carolina; 3Section of Hematology/Oncology, University of Chicago Cancer Research Center; Chicago, Illinois; 4Department of Surgery, Brigham and Women's Hospital & Harvard Medical School; Boston, Massachusetts; 5Department of Internal Medicine, Ohio State University; Columbus, Ohio; and 6Division of Medical Oncology, University of California, San Francisco, California Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber... From Brigham and Women’s Hospital, Boston (M.M.B.), and the Food and Drug Administration, Silver Spring, MD (H.S.). Office of the Director, National Institutes of Health , Bethesda, MD, USA Donna Niedzwiecki, Duke University, Durham, NC; Wendy L. Frankel, The Ohio State University, Columbus, OH; Alan P. Venook, University of California, San Francisco, San Francisco, CA; Xing Ye, Duke University, Durham, NC; Paula N. Friedman, Northwestern University, Chicago, IL; Richard M. Goldberg, The Ohio State University, Columbus, OH; Robert J. Mayer, Dana-Farber Cancer Institute, Boston, MA; Thomas A. Colacchio, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Jude Marie Mulligan, Timothy S. Davison,... Brigham and Women’s Hospital, Boston, MA Authors' Affiliation: Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts From the Oregon Health and Science University Cancer Institute; and Portland Veterans Affairs Medical Center, Portland, OR; Cancer and Leukemia Group B Statistical Center; and Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC; Cleveland Clinic Foundation, Cleveland, OH; Dana-Farber/Harvard Cancer Center; and Departments of Surgery and of Pathology, Brigham and Women's Hospital, Boston, MA; Fox Chase Cancer Center, Philadelphia, PA; Southwest Oncology Group... Brigham and Women's Hospital, Boston, MA Donna Niedzwiecki and Xing Ye, Duke University, Durham; Federico Innocenti, University of North Carolina at Chapel Hill, Chapel Hill, NC; Wendy L. Frankel and Richard M. Goldberg, The Ohio State University, Columbus, OH; Alan P. Venook and Robert S. Warren, University of California-San Francisco, San Francisco, CA; Paula N. Friedman, The University of Chicago, Chicago, IL; Robert J. Mayer, Dana-Farber Cancer Institute; Monica M. Bertagnolli, Brigham and Women’s Hospital, Boston, MA; Thomas Anthony... Department of Surgery Division of Surgical Oncology Brigham and Women's Hospital Boston Massachusetts Department of Surgery, Brigham and Women’s Hospital, Boston, Massachusetts, USA Dana-Farber/Partners CancerCare, Harvard Medical School, Boston, MA From the Brigham and Women's Hospital; Dana-Farber Cancer Institute, Boston, MA; Cancer and Leukemia Group B Statistical Center, Duke University Medical Center, Durham; University of North Carolina at Chapel Hill, Chapel Hill, NC; National Cancer Institute, Bethesda, MD; Ohio State University, Columbus, OH; Memorial Sloan-Kettering Cancer Center, New York, NY; and the University of California at San Francisco, San Francisco, CA. Brigham and Women's Hospital, Dana Farber Cancer Institute, Boston, MA 6Brigham and Women’s Hospital, Boston, Massachusetts 1Brigham and Women's Hospital;; 2Dana-Farber Cancer Institute, Boston, Massachusetts; Authors' Affiliations: Departments of 1Surgery, 2Pathology, and 3Medicine, Brigham and Women's Hospital; 4Department of Medicine, Massachusetts General Hospital, Boston Massachusetts; 5Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center; 6Pfizer, Inc., New York, New York; 7Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada; 8Hines Veteran's Administration Medical Center, Hines, Illinois; 9Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland; 10Department of Medicine, The Mayo Clinic, Rochester, Minnesota; and 11National Cancer Institute, Bethesda, Maryland Authors' Affiliations: 1Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School; 2Channing Laboratory, Department of Medicine, 3Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 4Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York; and 5MD Anderson Cancer Center, Houston, Texas Authors' Affiliations: 1Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School; 2Channing Laboratory, Department of Medicine, 3Center for Cardiovascular Disease Prevention, Department of Medicine, and 4Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 5Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York; and 6MD Anderson Cancer Center, Houston, Texas Authors' Affiliations: 1Department of Surgery, Division of Surgical Oncology, 2Center for Genomic Medicine, Channing Laboratory, Brigham and Women's Hospital, Boston, Massachusetts; 3Genome Center and Department of Biochemistry and Molecular Medicine, University of California, Davis, California; 4Department of Epidemiology and Statistics, Memorial Sloan-Kettering Cancer Center, New York; 5RIKEN Center for Genomic Medicine, Tokyo, Japan; 6Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and MRC Human Genetics Unit, Edinburgh; 7Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 8Ludwig Colon Cancer Initiative Laboratory, Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville; 9Genetic and Molecular Epidemiology Laboratories, and 10Familial Cancer laboratory, Queensland Institute of Medical Research, Brisbane; 11Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East |
Incoming Links
Total number of triples: 197.